ARCHIVES

Zevalin Regimen Better Than Rituximab Alone For NHL

This article is from The Cancer Letter archive.

Vol. 24 No. 6 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 4 Issue 1, Winter 1990

January 13, 1990

House approves $210 million for Dept. of Defense cancer research programs.

June 24, 2005

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

April 3, 1992

National Cancer Policy Board a Successful Experiment, NCI Says; Funding Extended

May 19, 2000

Intense Therapies Better Than Lower Dose For AML

November 26, 2004

NIH Slow To Implement Equality In Studies, GAO Says, But Waxman Assures Reauthorization

June 22, 1990